In this study, we explored the association between ncRNA expression and glioma OS, and obtained a prognostic signature containing three ncRNAs, including USP46‐AS1, PON2 and LOC441179, based on which we could accurately separate glioma patients with better prognosis from those with a worse prognosis. The gene discussed is PON2; the disease is glioma.